Treatment of OFF episodes in Parkinson's disease: An evaluation of physician practices

被引：0
|
作者：
Pappert, E. J.
Agro, A.
deGruyther, N.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
838
引用
收藏
页码：S271 / S272
页数：2
相关论文
共 50 条
  • [21] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Hauser, Robert
    Dzyngel, Bruce
    Bilbault, Thierry
    Shill, Holly
    Argo, Albert
    NEUROLOGY, 2016, 86
  • [22] Efficacy of apomorphine sublingual film versus subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's Disease
    Stocchi, F.
    Rascol, O.
    Poewe, W.
    Chaudhuri, R.
    Kassubek, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    MOVEMENT DISORDERS, 2022, 37 : S356 - S356
  • [23] Effective Management of "OFF" Episodes in Parkinson's Disease: Emerging Treatment Strategies and Unmet Clinical Needs
    Masood, Nbaa
    Jimenez-Shahed, Joohi
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 247 - 266
  • [24] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S47 - S47
  • [25] Efficacy of sublingual apomorphine (APL-130277) for the treatment of "Off" episodes in patients with Parkinson's disease
    Hauser, R. A.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 249 - 249
  • [26] Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease
    Isaacson, S.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 250 - 250
  • [27] Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Chaudhuri, R.
    Kassube, J.
    Manzanares, L. Lopez
    Leta, V.
    Zhang, I.
    Bowling, A.
    Wu, S.
    Pappert, E.
    MOVEMENT DISORDERS, 2022, 37 : S348 - S348
  • [28] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of "Off" Episodes in Patients with Parkinson's Disease
    Hauser, Robert A.
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Shill, Holly
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S44 - S44
  • [29] ANTIEMETICS MAY NOT BE NECESSARY FOR TITRATION OF APOMORPHINE SUBLINGUAL FILM FOR THE TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Hauser, R. A.
    Factor, S. A.
    Ondo, W. G.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 43
  • [30] Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Isaacson, Stuart
    Pappert, Eric
    Dzyngel, Bruce
    Bllbault, Thierry
    Argo, Albert
    NEUROLOGY, 2016, 86
12345